StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: AspenBio Pharma, Inc.

Enter Symbol or Keywords

AspenBio's OPS Ranking Downgraded by StockDiagnostics.com

Stock Quote: (NCM:APPY)

11/11/2009

2.15

-0.16

-6.93%

52,595

AspenBio's OPS Ranking Downgraded by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 11, 2009-AspenBio, Inc. (NASDAQ:APPY) reported negative OPS (Operational-cashflow Per Share) for its quarter ended September 30, 2009 and StockDiagnostics.com has downgraded its ... read full story

Website Address:	www.aspenbioinc.com
Industry:	Biomaterial & Tissue Engineering

Most Recent STN Exclusives

02/10/2010

Cash Flow from Operations for Western Digital Reaches Sixteen Year High

02/10/2010

Cash Flow from Operations Increases 53% for Helmerich & Payne

02/10/2010

T12-NEWS reports that the Revenue of KB Home for its 3 month ended November 30, 2009 Decreased by -26.6%

02/10/2010

Second Quarter Cash Flow from Operations Turns Positive for Emulex

02/10/2010

Most recent 12 month Revenue for DeVry Increased by 36.35% as reported by T12-NEWS

02/10/2010

Four Year Low in EBITDA for Carnival

02/10/2010

Free Cash Flow for Novartis Increases 88%

02/10/2010

StockDiagnostics.com Reiterates Lennar's OPS Ranking of "1"

02/10/2010

Estee Lauder Experiencing Revenue Downtrend While its Industry is in an Uptrend

02/10/2010

Cash Flow from Operations for Molex Reaches Five Year Low

Interactive Chart: APPY

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: APPY

11/13/2009

AspenBio's EBITDA Hits Six Year Low

11/11/2009

Revenue for AspenBio Decreases by -58.89% even though Revenue for Diagnostic Kits and Equipment Industry Increases by 12.02% over Latest 12 Months

11/11/2009

AspenBio's OPS Ranking Downgraded by StockDiagnostics.com

... more APPY exclusives

Other News Sources: APPY

02/09/2010

AspenBio Pharma Reports on AppyScore(TM) Supplemental Clinical Trial Interim Analysis and Provides Guidance on FDA 510(k) Filing

01/29/2010

APPY: Drops -5.02%; Vol +111%; Last 90 Min of Trading

01/28/2010

AspenBio Pharma Enters Into Development and Supply Agreement for AppyScore(TM) Reader

... more APPY news from other sources

Daily Market Updates

02/10/2010

Stocks Decline in Early Trading Following Bernanke's Comments

Stocks opened flat and declined as investors digested remarks this morning from Fed Chairman Ben Bernanke in remarks to the House Financial Services Committee. Chairman Bernanke said that the Fed will begin pulling back its stimulus for the U.S. econ ... read full story